Examination of the neural basis of psychotic-like experiences in adolescence during processing of emotional faces.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
20 03 2020
Historique:
received: 21 05 2019
accepted: 24 02 2020
entrez: 22 3 2020
pubmed: 22 3 2020
medline: 7 1 2021
Statut: epublish

Résumé

Contemporary theories propose that dysregulation of emotional perception is involved in the aetiology of psychosis. 298 healthy adolescents were assessed at age 14- and 19-years using fMRI while performing a facial emotion task. Psychotic-like experiences (PLEs) were assessed with the CAPE-42 questionnaire at age 19. The high PLEs group at age 19 years exhibited an enhanced response in right insular cortex and decreased response in right prefrontal, right parahippocampal and left striatal regions; also, a gradient of decreasing response to emotional faces with age, from 14 to 19 years, in the right parahippocampal region and left insular cortical area. The right insula demonstrated an increasing response to emotional faces with increasing age in the low PLEs group, and a decreasing response over time in the high PLEs group. The change in parahippocampal/amygdala and insula responses during the perception of emotional faces in adolescents with high PLEs between the ages of 14 and 19 suggests a potential 'aberrant' neurodevelopmental trajectory for critical limbic areas. Our findings emphasize the role of the frontal and limbic areas in the aetiology of psychotic symptoms, in subjects without the illness phenotype and the confounds introduced by antipsychotic medication.

Identifiants

pubmed: 32198484
doi: 10.1038/s41598-020-62026-7
pii: 10.1038/s41598-020-62026-7
pmc: PMC7083946
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5164

Subventions

Organisme : MRF
ID : MRF_MRF-058-0004-RG-DESRI
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R00465X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0901868
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N000390/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S020306/1
Pays : United Kingdom
Organisme : MRF
ID : MRF_MRF-058-0009-RG-DESR-C0759
Pays : United Kingdom

Références

Van, O. J., Linscott, R., Myin-Germeys, I., Delespaul, P. & Krabbendam, L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol. Med. 39, 179–195 (2010).
doi: 10.1017/S0033291708003814
Nelson, B., Fusar-Poli, P. & Yung, A. R. Can we detect psychotic-like experiences in the general population? Curr. Pharm. Des. 18, 376–385 (2012).
doi: 10.2174/138161212799316136
Verdoux, H. & van Os, J. Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophr. Res. 54, 59–65 (2002).
doi: 10.1016/S0920-9964(01)00352-8
Satterthwaite, T. D. et al. Structural Brain Abnormalities in Youth with Psychosis Spectrum Symptoms. JAMA Psychiatry. 73, 515–524 (2016).
doi: 10.1001/jamapsychiatry.2015.3463
Fusar-Poli, P. et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry. 70, 107–120 (2013).
doi: 10.1001/jamapsychiatry.2013.269
Arseneault, L. et al. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. Brit Med. J. 325, 1212–1213 (2002).
doi: 10.1136/bmj.325.7374.1212
Kelleher, I. & Cannon, M. Psychotic-like experiences in the general population: characterizing a high-risk group for psychosis. Psychol. Med. 41, 1–6 (2011).
doi: 10.1017/S0033291710001005
Van O, J., Verdoux, H. & Hanssen, M. CAPE42, http://cape42.homestead.com/ (2019)
Tremeau, F. A review of emotion deficits in schizophrenia. Dialogues Clin. Neurosci. 8, 59–70 (2006).
pubmed: 16640115 pmcid: 3181757
Anticevic, A. et al. Amygdala recruitment in schizophrenia in response to aversive emotional material: a meta-analysis of neuroimaging studies. Schizophr. Bull. 38, 608–621 (2012).
doi: 10.1093/schbul/sbq131
Pinkham, A. E., Hopfinger, J. B., Pelphrey, K. A., Piven, J. & Penn, D. L. Neural bases for impaired social cognition in schizophrenia and autism spectrum disorders. Schizophr. Res. 99, 164–175 (2008).
doi: 10.1016/j.schres.2007.10.024
Stahl, S. M. Psychosis and Schizophrenia. Stahl’s Essential Psychopharmacology, Neuroscientific Basis and Practical Applications 79–128 (Cambridge University Press, 2013).
Silverstein, S. M. et al. Increased fusiform area activation in schizophrenia during processing of spatial frequency-degraded faces, as revealed by fMRI. Psychol. Med. 40, 1159–1169 (2012).
doi: 10.1017/S0033291709991735
Hall, J. et al. Overactivation of fear systems to neutral faces in schizophrenia. Biol. Psychiatry. 64, 70–73 (2008).
doi: 10.1016/j.biopsych.2007.12.014
Modinos, G., Ormel, J. & Aleman, A. Altered activation and functional connectivity of neural systems supporting cognitive control of emotion in psychosis proneness. Schizophr. Res. 118, 88–97 (2010).
doi: 10.1016/j.schres.2010.01.030
Bourque, J. et al. Functional Neuroimaging Predictors of Self-Reported Psychotic Symptoms in Adolescents. Am. J. psychiatry. 174, 566–575 (2017).
doi: 10.1176/appi.ajp.2017.16080897
Roiser, J. P., Howes, O. D., Chaddock, C. A., Joyce, E. M. & McGuire, P. Neural and behavioral correlates of aberrant salience in individuals at risk for psychosis. Schizophr. Bull. 39, 1328–1336 (2012).
doi: 10.1093/schbul/sbs147
Peters, E., Joseph, S., Day, S. & Garety, P. Measuring delusional ideation: the 21-item Peters et al. Delusions Inventory (PDI). Schizophr. Bull. 30, 1005–1022 (2004).
doi: 10.1093/oxfordjournals.schbul.a007116
Peters, E. R., Joseph, S. A. & Garety, P. A. Measurement of delusional ideation in the normal population: introducing the PDI (Peters et al. Delusions Inventory). Schizophr. Bull. 25, 553–576 (1999).
doi: 10.1093/oxfordjournals.schbul.a033401
Sahakian, B. & Owen, A. Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J. R. Soc. Medicine. 85, 399–402 (1992).
Grosbras, M. H. & Paus, T. Brain networks involved in viewing angry hands or faces. Cereb. Cortex. 16, 1087–1096 (2006).
doi: 10.1093/cercor/bhj050
Schneider, S. et al. Boys do it the right way: Sex-dependent amygdala lateralization during face processing in adolescents. NeuroImage. 56, 1847–1853 (2011).
doi: 10.1016/j.neuroimage.2011.02.019
Wang, X. et al. The Hierarchical Structure of the Face Network Revealed by Its Functional Connectivity Pattern. J. Neurosci. 36, 890–900 (2016).
doi: 10.1523/JNEUROSCI.2789-15.2016
Mossaheb, N. et al. The Community Assessment of Psychic Experience (CAPE) questionnaire as a screening-instrument in the detection of individuals at ultra-high risk for psychosis. Schizophr. Res. 141, 210–214 (2012).
doi: 10.1016/j.schres.2012.08.008
Schumann, G. et al. The IMAGEN study: reinforcement-related behaviour in normal brain function and psychopathology. Mol. Psychiatry. 15, 1128–1139 (2010).
doi: 10.1038/mp.2010.4
Friston, K. J., Rotshtein, P., Geng, J. J., Sterzer, P. & Henson, R. N. A critique of functional localisers. NeuroImage. 30, 1077–1087 (2006).
doi: 10.1016/j.neuroimage.2005.08.012
Adolphs, R. The neurobiology of social cognition. Curr. Opin. Neurobiol. 11, 231–239 (2001).
doi: 10.1016/S0959-4388(00)00202-6
Hill, K. et al. Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies. Acta Psychiatr. Scand. 110, 243–256 (2004).
doi: 10.1111/j.1600-0447.2004.00376.x
Callicott, J. H. et al. Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. Am. J. Psychiatry. 160, 2209–2215 (2003).
doi: 10.1176/appi.ajp.160.12.2209
Fornito, A. et al. Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis. JAMA Psychiatry. 70, 1143–1151 (2013).
doi: 10.1001/jamapsychiatry.2013.1976
Fusar-Poli, P. et al. Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 31, 465–484 (2007).
doi: 10.1016/j.neubiorev.2006.11.006
Tseng, H.-H. et al. Corticolimbic dysfunction during facial and prosodic emotional recognition in first-episode psychosis patients and individuals at ultra-high risk. NeuroImage: Clinical. 12, 645–654 (2016).
doi: 10.1016/j.nicl.2016.09.006
Wilkinson, D. & Halligan, P. The relevance of behavioural measures for functional-imaging studies of cognition. Nat. Rev. Neurosci. 5(1), 67–73 (2004).
doi: 10.1038/nrn1302
McGrath, J. J. et al. Psychotic Experiences in the General Population: A Cross-National Analysis Based on 31,261 Respondents From 18 Countries. JAMA Psychiatry. 72, 697–705 (2015).
doi: 10.1001/jamapsychiatry.2015.0575
Aleman, A., Kahn, R. S. & Selten, J. P. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch. Gen. Psychiat. 60, 565–571 (2003).
doi: 10.1001/archpsyc.60.6.565
Modinos, G. et al. Neural correlates of aberrant emotional salience predict psychotic symptoms and global functioning in high-risk and first-episode psychosis. Soc. Cogn. Affect. Neurosci. 10, 1429–1436 (2015).
doi: 10.1093/scan/nsv035
Papanastasiou, E. et al. Examination of the Neural Basis of Psychoticlike Experiences in Adolescence During Reward Processing. JAMA. Psychiatry. 75, 1043–1051 (2018).
Wechsler, D. Wechsler Intelligence Scale for Children, Fifth Edition, https://www.pearsonassessments.com/store/usassessments/en/Store/Professional-Assessments/Cognition-%26-Neuro/Gifted-%26-Talented/Wechsler-Intelligence-Scale-for-Children-%7C-Fifth-Edition-/p/100000771.html?tab=product-details# (2014)
Revah-Levy, A., Birmaher, B., Gasquet, I. & Falissard, B. The Adolescent Depression Rating Scale (ADRS): a validation study. BMC Psychiatry. 7, 1–10 (2007).
doi: 10.1186/1471-244X-7-2
Bohn, M. J., Babor, T. F. & Kranzler, H. R. The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. J. Stud. alcohol. 56, 423–432 (1995).
doi: 10.15288/jsa.1995.56.423
Skinner, H. A. The drug abuse screening test. Addictive behaviors. 7, 363–371 (1982).
doi: 10.1016/0306-4603(82)90005-3

Auteurs

Evangelos Papanastasiou (E)

Cognition Schizophrenia and Imaging Laboratory, Department of Psychosis Studies, Institute of Psychiatry Psychology and Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London, SE5 8AF, United Kingdom. evangelos.e.papanastasiou@kcl.ac.uk.

Elias Mouchlianitis (E)

Cognition Schizophrenia and Imaging Laboratory, Department of Psychosis Studies, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, United Kingdom.

Dan W Joyce (DW)

Cognition Schizophrenia and Imaging Laboratory, Department of Psychosis Studies, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, United Kingdom.

Philip McGuire (P)

Department of Psychosis Studies, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, United Kingdom.

Celia Boussebaa (C)

Cognition Schizophrenia and Imaging Laboratory, Department of Psychosis Studies, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, United Kingdom.

Tobias Banaschewski (T)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Arun L W Bokde (ALW)

Discipline of Psychiatry, School of Medicine and Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin, Ireland.

Christian Büchel (C)

Department of Systems Neuroscience, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Erin Quinlan (E)

Centre for Population Neuroscience and Precision Medicine, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, United Kingdom.
Medical Research Council, Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, United Kingdom.

Sylvane Desrivières (S)

Centre for Population Neuroscience and Precision Medicine, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, United Kingdom.
Medical Research Council, Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, United Kingdom.

Herta Flor (H)

Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Department of Psychology, School of Social Sciences, University of Mannheim, Mannheim, Germany.

Antoine Grigis (A)

NeuroSpin, CEA, Université Paris-Saclay, Gif-sur-Yvette, France.

Hugh Garavan (H)

Department of Psychiatry, University of Vermont, Burlington, Vermont, USA.
Department of Psychology, University of Vermont, Burlington, Vermont, USA.

Philip Spechler (P)

Department of Psychiatry, University of Vermont, Burlington, Vermont, USA.
Department of Psychology, University of Vermont, Burlington, Vermont, USA.

Penny Gowland (P)

Sir Peter Mansfield Imaging Centre School of Physics and Astronomy, University of Nottingham, Nottingham, United Kingdom.

Andreas Heinz (A)

Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité, Universitätsmedizin Berlin, Berlin, Germany.

Bernd Ittermann (B)

Physikalisch-Technische Bundesanstalt, Berlin, Germany.

Marie-Laure Paillère Martinot (MP)

Institut National de la Santé et de la Recherche Médicale, Neuroimaging & Psychiatry, University Paris Sud - Paris-Saclay, University Paris Descartes, Paris, France.
Department of Adolescent Psychopathology and Medicine, Maison de Solenn, Cochin Hospital, Paris, France.

Eric Artiges (E)

Institut National de la Santé et de la Recherche Médicale, Neuroimaging & Psychiatry, DIGITEO Labs, University Paris Saclay, Gif-sur-Yvette, France.
Psychiatry Department, Orsay Hospital, Orsay, France.

Frauke Nees (F)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Department of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Dimitri Papadopoulos Orfanos (DP)

NeuroSpin, CEA, Université Paris-Saclay, Gif-sur-Yvette, France.

Tomáš Paus (T)

Bloorview Research Institute, Holland Bloorview Kids Rehabilitation Hospital and Departments of Psychology and Psychiatry, University of Toronto, Toronto, Ontario, Canada.

Luise Poustka (L)

Department of Child and Adolescent Psychiatry and Psychotherapy, University Medical Centre Göttingen, Göttingen, Germany.
Clinic for Child and Adolescent Psychiatry, Medical University of Vienna, Vienna, Austria.

Sabina Millenet (S)

Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Juliane H Fröhner (JH)

Department of Psychiatry and Neuroimaging Centre, Technische Universität Dresden, Dresden, Germany.

Michael N Smolka (MN)

Department of Psychiatry and Neuroimaging Centre, Technische Universität Dresden, Dresden, Germany.

Henrik Walter (H)

Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité, Universitätsmedizin Berlin, Berlin, Germany.

Robert Whelan (R)

School of Psychology and Global Brain Health Institute, Trinity College Dublin, Dublin, Ireland.

Gunter Schumann (G)

Centre for Population Neuroscience and Precision Medicine, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, United Kingdom.

Sukhwinder S Shergill (SS)

Cognition Schizophrenia and Imaging Laboratory, Department of Psychosis Studies, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, United Kingdom.
Centre for Population Neuroscience and Precision Medicine, Institute of Psychiatry Psychology and Neuroscience, King's College London, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH